Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.02
MDAS's Cash to Debt is ranked lower than
61% of the 2118 Companies
in the Global Health Information Services industry.

( Industry Median: 4.93 vs. MDAS: 0.02 )
MDAS' s 10-Year Cash to Debt Range
Min: 0   Max: No Debt
Current: 0.02

Equity to Asset 0.28
MDAS's Equity to Asset is ranked lower than
54% of the 2048 Companies
in the Global Health Information Services industry.

( Industry Median: 0.60 vs. MDAS: 0.28 )
MDAS' s 10-Year Equity to Asset Range
Min: -0.6   Max: 0.61
Current: 0.28

-0.6
0.61
Interest Coverage 1.93
MDAS's Interest Coverage is ranked lower than
60% of the 1326 Companies
in the Global Health Information Services industry.

( Industry Median: 1176.93 vs. MDAS: 1.93 )
MDAS' s 10-Year Interest Coverage Range
Min: 0.59   Max: 9999.99
Current: 1.93

0.59
9999.99
F-Score: 7
Z-Score: 0.88
M-Score: -2.59
WACC vs ROIC
9.89%
4.36%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 13.77
MDAS's Operating margin (%) is ranked higher than
74% of the 2100 Companies
in the Global Health Information Services industry.

( Industry Median: 5.37 vs. MDAS: 13.77 )
MDAS' s 10-Year Operating margin (%) Range
Min: -4.99   Max: 17.56
Current: 13.77

-4.99
17.56
Net-margin (%) 4.30
MDAS's Net-margin (%) is ranked higher than
57% of the 2100 Companies
in the Global Health Information Services industry.

( Industry Median: 3.67 vs. MDAS: 4.30 )
MDAS' s 10-Year Net-margin (%) Range
Min: -8.21   Max: 16.69
Current: 4.3

-8.21
16.69
ROE (%) 6.17
MDAS's ROE (%) is ranked higher than
56% of the 2033 Companies
in the Global Health Information Services industry.

( Industry Median: 6.20 vs. MDAS: 6.17 )
MDAS' s 10-Year ROE (%) Range
Min: -7.36   Max: 20.26
Current: 6.17

-7.36
20.26
ROA (%) 1.81
MDAS's ROA (%) is ranked higher than
59% of the 2126 Companies
in the Global Health Information Services industry.

( Industry Median: 3.37 vs. MDAS: 1.81 )
MDAS' s 10-Year ROA (%) Range
Min: -2.45   Max: 14.99
Current: 1.81

-2.45
14.99
ROC (Joel Greenblatt) (%) 60.17
MDAS's ROC (Joel Greenblatt) (%) is ranked higher than
72% of the 2105 Companies
in the Global Health Information Services industry.

( Industry Median: 29.03 vs. MDAS: 60.17 )
MDAS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -28.34   Max: 148.36
Current: 60.17

-28.34
148.36
Revenue Growth (3Y)(%) 17.10
MDAS's Revenue Growth (3Y)(%) is ranked higher than
89% of the 1666 Companies
in the Global Health Information Services industry.

( Industry Median: 5.60 vs. MDAS: 17.10 )
MDAS' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0   Max: 23.6
Current: 17.1

0
23.6
EBITDA Growth (3Y)(%) 72.30
MDAS's EBITDA Growth (3Y)(%) is ranked higher than
98% of the 1378 Companies
in the Global Health Information Services industry.

( Industry Median: 7.20 vs. MDAS: 72.30 )
MDAS' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: 72.3
Current: 72.3

0
72.3
» MDAS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

MDAS Guru Trades in Q1 2014

Mario Gabelli 11,500 sh (New)
Steven Cohen 1,099,241 sh (+53.59%)
Joel Greenblatt 34,198 sh (+33.27%)
Paul Tudor Jones Sold Out
Jim Simons 60,300 sh (-80.54%)
» More
Q2 2014

MDAS Guru Trades in Q2 2014

Paul Tudor Jones 9,800 sh (New)
Joel Greenblatt 52,010 sh (+52.08%)
Steven Cohen 245,600 sh (unchged)
Mario Gabelli 11,500 sh (unchged)
Jim Simons Sold Out
» More
Q3 2014

MDAS Guru Trades in Q3 2014

Paul Tudor Jones 25,815 sh (+163.42%)
Steven Cohen 538,000 sh (+119.06%)
Mario Gabelli 12,500 sh (+8.7%)
Joel Greenblatt 56,371 sh (+8.38%)
» More
Q4 2014

MDAS Guru Trades in Q4 2014

Paul Tudor Jones 55,316 sh (+114.28%)
Joel Greenblatt 58,929 sh (+4.54%)
Mario Gabelli 12,500 sh (unchged)
Steven Cohen Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with MDAS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-06-30 Add 52.08%0.01%$22.02 - $25.42 $ 19.21-18%52010
Mario Gabelli 2014-03-31 New Buy$19.58 - $25.74 $ 19.21-14%11500
Joel Greenblatt 2014-03-31 Add 33.27%$19.58 - $25.74 $ 19.21-14%34198
Joel Greenblatt 2013-12-31 New Buy0.01%$19.61 - $26.39 $ 19.21-15%25660
Mario Gabelli 2013-12-31 Sold Out $19.61 - $26.39 $ 19.21-15%0
Joel Greenblatt 2013-09-30 Sold Out 0.03%$17.49 - $25.42 $ 19.21-14%0
Mario Gabelli 2013-09-30 New Buy$17.49 - $25.42 $ 19.21-14%9500
Joel Greenblatt 2013-06-30 New Buy0.03%$16.4 - $19.14 $ 19.217%38584
George Soros 2011-12-31 Sold Out 0.0022%$8.91 - $12.32 $ 19.2194%0
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 39.50
MDAS's P/E(ttm) is ranked higher than
76% of the 2303 Companies
in the Global Health Information Services industry.

( Industry Median: 56.70 vs. MDAS: 39.50 )
MDAS' s 10-Year P/E(ttm) Range
Min: 36.57   Max: 1500.77
Current: 39.5

36.57
1500.77
Forward P/E 14.58
MDAS's Forward P/E is ranked higher than
92% of the 2303 Companies
in the Global Health Information Services industry.

( Industry Median: 0.00 vs. MDAS: 14.58 )
N/A
PE(NRI) 39.20
MDAS's PE(NRI) is ranked higher than
76% of the 2303 Companies
in the Global Health Information Services industry.

( Industry Median: 59.00 vs. MDAS: 39.20 )
MDAS' s 10-Year PE(NRI) Range
Min: 36.33   Max: 1951
Current: 39.2

36.33
1951
P/B 2.40
MDAS's P/B is ranked higher than
74% of the 2303 Companies
in the Global Health Information Services industry.

( Industry Median: 3.32 vs. MDAS: 2.40 )
MDAS' s 10-Year P/B Range
Min: 1.26   Max: 4.39
Current: 2.4

1.26
4.39
P/S 1.70
MDAS's P/S is ranked higher than
76% of the 2303 Companies
in the Global Health Information Services industry.

( Industry Median: 2.67 vs. MDAS: 1.70 )
MDAS' s 10-Year P/S Range
Min: 0.92   Max: 4.22
Current: 1.7

0.92
4.22
PFCF 13.70
MDAS's PFCF is ranked higher than
91% of the 2303 Companies
in the Global Health Information Services industry.

( Industry Median: 102.32 vs. MDAS: 13.70 )
MDAS' s 10-Year PFCF Range
Min: 5.2   Max: 46.77
Current: 13.7

5.2
46.77
POCF 8.43
MDAS's POCF is ranked higher than
91% of the 2303 Companies
in the Global Health Information Services industry.

( Industry Median: 28.43 vs. MDAS: 8.43 )
MDAS' s 10-Year POCF Range
Min: 3.83   Max: 25.22
Current: 8.43

3.83
25.22
EV-to-EBIT 21.51
MDAS's EV-to-EBIT is ranked higher than
77% of the 2303 Companies
in the Global Health Information Services industry.

( Industry Median: 36.34 vs. MDAS: 21.51 )
MDAS' s 10-Year EV-to-EBIT Range
Min: -107.8   Max: 47
Current: 21.51

-107.8
47
PEG 1.73
MDAS's PEG is ranked higher than
94% of the 2303 Companies
in the Global Health Information Services industry.

( Industry Median: 0.00 vs. MDAS: 1.73 )
MDAS' s 10-Year PEG Range
Min: 1.25   Max: 178.34
Current: 1.73

1.25
178.34
Shiller P/E 407.20
MDAS's Shiller P/E is ranked higher than
76% of the 2303 Companies
in the Global Health Information Services industry.

( Industry Median: 0.00 vs. MDAS: 407.20 )
MDAS' s 10-Year Shiller P/E Range
Min: 71.15   Max: 2571
Current: 407.2

71.15
2571
Current Ratio 0.62
MDAS's Current Ratio is ranked lower than
57% of the 2080 Companies
in the Global Health Information Services industry.

( Industry Median: 1.88 vs. MDAS: 0.62 )
MDAS' s 10-Year Current Ratio Range
Min: 0.55   Max: 2.77
Current: 0.62

0.55
2.77
Quick Ratio 0.62
MDAS's Quick Ratio is ranked lower than
56% of the 2080 Companies
in the Global Health Information Services industry.

( Industry Median: 1.77 vs. MDAS: 0.62 )
MDAS' s 10-Year Quick Ratio Range
Min: 0.55   Max: 2.77
Current: 0.62

0.55
2.77
Days Sales Outstanding 57.95
MDAS's Days Sales Outstanding is ranked higher than
79% of the 2303 Companies
in the Global Health Information Services industry.

( Industry Median: 84.50 vs. MDAS: 57.95 )
MDAS' s 10-Year Days Sales Outstanding Range
Min: 47.01   Max: 93.29
Current: 57.95

47.01
93.29

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 0.83
MDAS's Price/DCF (Projected) is ranked higher than
93% of the 2303 Companies
in the Global Health Information Services industry.

( Industry Median: 7.56 vs. MDAS: 0.83 )
MDAS' s 10-Year Price/DCF (Projected) Range
Min: 0.43   Max: 1.27
Current: 0.83

0.43
1.27
Price/Median PS Value 0.88
MDAS's Price/Median PS Value is ranked higher than
88% of the 2303 Companies
in the Global Health Information Services industry.

( Industry Median: 1.28 vs. MDAS: 0.88 )
MDAS' s 10-Year Price/Median PS Value Range
Min: 0.48   Max: 2.03
Current: 0.88

0.48
2.03
Price/Peter Lynch Fair Value 1.57
MDAS's Price/Peter Lynch Fair Value is ranked higher than
93% of the 2303 Companies
in the Global Health Information Services industry.

( Industry Median: 0.00 vs. MDAS: 1.57 )
MDAS' s 10-Year Price/Peter Lynch Fair Value Range
Min: 1.69   Max: 175
Current: 1.57

1.69
175
Earnings Yield (Greenblatt) 4.60
MDAS's Earnings Yield (Greenblatt) is ranked higher than
75% of the 2102 Companies
in the Global Health Information Services industry.

( Industry Median: 3.40 vs. MDAS: 4.60 )
MDAS' s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.1   Max: 5.1
Current: 4.6

2.1
5.1
Forward Rate of Return (Yacktman) 37.13
MDAS's Forward Rate of Return (Yacktman) is ranked higher than
95% of the 1125 Companies
in the Global Health Information Services industry.

( Industry Median: 12.92 vs. MDAS: 37.13 )
MDAS' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 5.3   Max: 37.5
Current: 37.13

5.3
37.5

Business Description

Industry: Application Software » Health Information Services
Compare: » details
Traded in other countries:58M.Germany,
MedAssets, Inc., was incorporated in 1999. It is a financial and performance improvement company providing technology-enabled products and services that, together, help mitigate the increasing financial challenges faced by hospitals, health systems, and other non-acute healthcare providers. Its solutions are designed to reduce the total cost of care delivery, enhance operational efficiency, align clinical delivery of physicians and staff to advance care coordination, and improve revenue performance mainly for hospitals and health systems. The Company's solutions integrate with its clients' existing operations and enterprise software systems, and require minimal upfront costs or capital expenditures for its clients. Its technology-enabled solutions are delivered through company-hosted software, sometimes referred to as software as a service or Web-based applications, supported by implementation, process improvement consulting and outsourced services, as well as enterprise-wide sales and client management support. The Company manages its business through two business segments, Spend and Clinical Resource Management (CM) and Revenue Cycle Management (RCM). Within the SCM segment it provides a comprehensive suite of cost management services, supply chain analytics and data capabilities that help its clients reduce their total cost of care delivery, enhance their operational efficiency and align their clinicians' delivery of care with advance care coordination. Its solutions lower operating costs through compliance to its strategic sourcing of supplies and purchased services at discounted prices, supply chain outsourcing and procurement services capabilities. It also help to improve care processes and reduce care variations through the use of its clinical and process improvement consulting services, workforce optimization solutions and business analytics and intelligence tools. The Company's RCM segment is a provider of revenue cycle management solutions to healthcare providers, mainly hospitals and health systems. It provides SaaS or Web-based software and technology-enabled services designed to improve revenue performance for healthcare organizations through patient access and financial responsibility, clinical documentation, charge capture and revenue integrity, pricing analysis, claims processing and denials management, payor contract management, extended business office revenue recovery, accounts receivable services and outsourcing. As of December 31, 2013, the Company's client base included more than 4,400 acute care hospitals and approximately 122,000 ancillary or non-acute provider locations. The Company competes with Allscripts Corporation, Epic Systems Corporation, McKesson Corporation, Siemens AG; Accenture Ltd., Accretive Health, Inc., Deloitte & Touche LLP, Ernst & Young LLP, Craneware Inc., Emdeon Inc. and among others. The Company is subject to federal and state laws and regulations designed to protect patients, governm
» More Articles for MDAS

Headlines

Articles On GuruFocus.com
Weekly CEO Buys Highlight: APD, MDAS, PNNT, MDU, SRV Feb 23 2015 
Weekly CEO Sells Highlight: Amazon.com Inc, Atmel Corporation, Monolithic Power Systems Inc, MedAsse Nov 10 2013 
Steven Cohen Increases Two High-Growth Positions - OCZ Technology and MedAssets Inc. Apr 17 2012 
MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 9,000 Shares Mar 08 2011 
MEDASSETS, INC. Reports Operating Results (10-K) Mar 01 2011 
MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares Feb 09 2011 
MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares Jan 05 2011 
MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares Dec 08 2010 
MEDASSETS, INC. (MDAS) Chairman, President and CEO John A Bardis sells 40,000 Shares Dec 01 2010 
MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares Nov 09 2010 

More From Other Websites
MedAssets to Present at the Barclays Global Healthcare Conference on March 11th Feb 26 2015
MedAssets to Present at the Barclays Global Healthcare Conference on March 11th Feb 26 2015
MedAssets National Collaborative Program Delivers Measurable Savings, Links Value to Financial Goals... Feb 25 2015
MedAssets National Collaborative Program Delivers Measurable Savings, Links Value to Financial Goals... Feb 25 2015
MedAssets Beats on Earnings and Revenues, Outlook Tepid - Analyst Blog Feb 19 2015
MedAssets (MDAS) Crumbles: Stock Tumbles 9.7% - Analyst Blog Feb 19 2015
MedAssets downgraded by Deutsche Bank Feb 18 2015
MedAssets (MDAS) Stock Is Down Today on Light Guidance Feb 18 2015
MedAssets reports 4Q loss Feb 18 2015
MedAssets reports 4Q loss Feb 18 2015
MEDASSETS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Feb 17 2015
MedAssets Reports Fourth Quarter and Full-Year 2014 Financial Results Feb 17 2015
MedAssets Announces Extension of Share Repurchase Plan and Increase to $100 Million Feb 17 2015
John A. Bardis to Retire; R. Halsey Wise Named Chairman and CEO of MedAssets Feb 17 2015
HackensackUMC Mountainside Expands and Renews Revenue Cycle Outsourcing Relationship With MedAssets... Feb 11 2015
Lakeland Regional Medical Center Expands Relationship With MedAssets for Advisory Solutions to Align... Feb 03 2015
MedAssets to Report Fourth Quarter and Full-Year 2014 Financial Results on Wednesday, February 25th... Jan 22 2015
MedAssets to Report Fourth Quarter and Full-Year 2014 Financial Results on Wednesday, February 25th... Jan 22 2015
MEDASSETS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jan 13 2015
MEDASSETS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... Jan 06 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK